Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis.
about
Review article: orofacial granulomatosisAssociation between orofacial granulomatosis and Crohn's disease in children: systematic review.Granulomatous cheilitis: successful treatment of two recalcitrant cases with combination drug therapy.Oropharyngeal Crohn's disease.Unifocal orofacial granulomatosis in retromolar mucosa: surgical treatment with Er,Cr:YSGG laser.Mucosal disease series. Number VI. Recurrent aphthous stomatitis.Orofacial granulomatosis: A case report with review of literature.Thalidomide for inflammatory bowel disease: Systematic review.What can we learn about biofilm/host interactions from the study of inflammatory bowel disease.Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesisBuccal localization of Crohn's disease with long-term infliximab therapy: a case report.The clinical implications of thalidomide in inflammatory bowel diseases.Riga-Fede-like disease in a 70 year old woman.Review article: non-malignant oral manifestations in inflammatory bowel diseases.Service evaluation of patients with orofacial granulomatosis and patients with oral Crohn's disease attending a paediatric oral medicine clinic.Anti-TNF-alpha therapy for orofacial granulomatosis: proceed with cautionIs there a role for tumor necrosis factor-alpha inhibitors and especially thalidomide in dermatology?Treatment-resistant lingual Crohn's disease disappears after infliximab.Clinical behaviour and long-term therapeutic response in orofacial granulomatosis patients treated with intralesional triamcinolone acetonide injections alone or in combination with topical pimecrolimus 1%.
P2860
Q28295522-6467E2E4-AE75-4CE4-B9CE-AC5F3918E571Q33780232-810946D4-F8EB-4629-989A-99F5DE3782FAQ34419482-C1225D78-EAD1-4E28-815E-2A429056F604Q35026236-956AECCF-DD8F-4FB4-A0F9-0A3B7FE262E7Q35162096-CB680602-5D12-456D-8906-94EB8EB62154Q36359427-E28E9AD1-5681-451B-B013-2DE5B6A332FBQ36400781-1CF2CFF8-9B01-44C3-9C91-E5EA4A788989Q37605607-4C6C2855-D17D-4534-86D3-63C5F343AF19Q37842621-7936E56B-813A-4519-9FA4-FBB20E4FE648Q37862587-F75C6CBA-34C9-4160-93DC-6354D22384C3Q38272633-762B91CC-355C-4D5A-B46E-FCED4A0A3FA7Q38417116-77FF15EE-233E-40ED-BE5C-424E0AF5E845Q38431881-5D31E3E9-F887-4EF3-917B-EA0165451B3FQ38445073-4A1E0B06-4F2B-4275-8A59-46D11982C6E6Q39243631-410C8CFB-F2A6-4BD2-B444-47C0AA666F13Q42844222-2FDA76DC-9330-4AE4-AF39-B096B28579A5Q45226912-F8872C20-B35A-4A65-B2D3-C472C6D56968Q46787457-FD71379D-692A-44B3-B446-AADCBD71BB0BQ47396459-698C3CDB-9DA2-4D65-92DB-F88BE1A4B81C
P2860
Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Thalidomide for the treatment ...... and orofacial granulomatosis.
@en
Thalidomide for the treatment ...... and orofacial granulomatosis.
@nl
type
label
Thalidomide for the treatment ...... and orofacial granulomatosis.
@en
Thalidomide for the treatment ...... and orofacial granulomatosis.
@nl
prefLabel
Thalidomide for the treatment ...... and orofacial granulomatosis.
@en
Thalidomide for the treatment ...... and orofacial granulomatosis.
@nl
P2093
P356
P1476
Thalidomide for the treatment ...... and orofacial granulomatosis.
@en
P2093
Anne Hegarty
Stephen Porter
Tim Hodgson
P304
P356
10.1067/MOE.2002.113
P577
2003-05-01T00:00:00Z